Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use INVEGA HAFYERA safely and effectively. See full prescribing information for INVEGA HAFYERA. INVEGA HAFYERA ® (paliperidone palmitate) extended-release injectable suspension, for gluteal intramuscular use Initial U.S. Approval: 2006
Medication labelWhy this: Advisory · dailymed-prescription
INVEGA HAFYERA, an every-six-month injection, is indicated for the treatment of schizophrenia in adults after they have been adequately treated with: A once-a-month paliperidone palmitate extended-release injectable suspension (e.g., INVEGA SUSTENNA) for at least four months, or An every-three-month paliperidone palmitate extended-release injectable suspension (e.g., INVEGA TRINZA) for at least one three-month cycle.
- generic_name
- paliperidone palmitate
- product_names
- paliperidone palmitate
- ndc
- 50458-611, 50458-612, 50458-611-01, 50458-612-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en